MOUNT SINAI MEDICAL CENTER OF FLORID
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $11.5M
- Transactions
- 2,328
- Companies
- 40
- Average per transaction
- $4,943
Who reported the payments
| Aadi Bioscience, Inc. | $2,176,749 |
| Boehringer Ingelheim International GmbH | $1,302,000 |
| Eli Lilly | $641,166 |
| Genentech, Inc. | $607,433 |
| Beigene, Ltd. | $560,126 |
| Janssen Research & Development, LLC | $496,165 |
| Merck | $483,594 |
| Pfizer | $402,049 |
| Incyte Corporation | $394,231 |
| E.r. Squibb & Sons, L.L.C. | $370,724 |
| AstraZeneca | $315,122 |
| AbbVie | $296,816 |
| Intuitive Surgical | $253,907 |
| Amgen | $228,147 |
| Mirati Therapeutics, Inc. | $174,923 |
| Edwards Lifesciences | $172,201 |
| Taiho Oncology, Inc. | $133,743 |
| Daiichi Sankyo Inc. | $126,657 |
| GE HealthCare | $121,771 |
| Exelixis Inc. | $120,346 |
| Eisai Inc. | $113,668 |
| Medtronic | $103,500 |
| Bristol Myers Squibb | $96,423 |
| Otsuka Pharmaceutical Co., Ltd. | $95,612 |
| Boston Scientific | $89,868 |
| Inari Medical, Inc. | $89,236 |
| Novartis | $86,700 |
| Regeneron | $85,327 |
| Rigel Pharmaceuticals, Inc. | $84,726 |
| Bard Peripheral Vascular, Inc. | $83,326 |
| Seagen Inc. | $76,249 |
| Iovance Biotherapeutics, Inc. | $73,539 |
| Genmab U.S., Inc. | $57,430 |
| Ipsen Bioscience Inc. | $54,037 |
| F. Hoffmann-la Roche AG | $47,395 |
| Genmark Diagnostics, Inc. | $46,268 |
| Silk Road Medical, Inc. | $43,850 |
| Stryker | $43,515 |
| Novocure Inc. | $41,048 |
| Gilead | $37,651 |